CONGENITAL HEART DEFECT IN A PREGNANT WOMAN (CLINICAL CASE)
Main Article Content
Abstract
Currently, there is an increase in patients with congenital heart defects. The number of women with cardiovascular pathology planning and carrying a pregnancy does not decrease. Doctors observing such patients must be highly qualified experts in the diagnosis and management of women with various specific congenital heart defects.
Patients with congenital heart defects very often stop regular medical monitoring with satisfactory health, timely and successful surgical correction of defects. However, it is necessary to remember that when planning a pregnancy in this group of patients, they need medical supervision. They can fall into the group of high-risk patients requiring monitoring by highly qualified specialists.
To optimize care for pregnant women with congenital heart defects and achieve positive results, it is necessary to interact with doctors of different specialties: obstetricians-gynecologists, therapists, cardiologists, cardiac surgeons and specialists in congenital heart defects.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739-2791. doi: 10.1093/eurheartj/ehx391
Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2017; 135(8): e50-e87. doi: 10.1161/CIR.0000000000000458
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377(7): 613-622. doi: 10.1056/NEJMoa1704559
Van Hagen IM, Roos-Hesselink JW, Ruys TP, Merz WM, Goland S, Gabriel H, et al. Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015; 132(2): 132-142. doi: 10.1161/CIRCULATIONAHA.115.015242
Roos-Hesselink JW, Ruys TP, Stein J, Thilen U, Webb GD, Niwa K, et al. Outcome of pregnancy in patients with structural or ischaemicheart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013; 34(9): 657-665. doi: 10.1093/eurheartj/ehs270
Drenthen W, Boersma E, Balci A, Moons P, Jolien W, Roos-Hesselink, et al. Predictors of pregnancy complications in women with congenital disease. Eur Heart J. 2010; 31(17): 2124-2132. doi: 10.1093/eurheartj/ehq200
European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Committee for Practice Guidelines.Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the management of Cardiovascular Diseases during Pregnancy. Eur Heart J. 2011; 32(24): 3147-3197. doi: 10.1093/eurheartj/ehr218
Fernandes SM, Arendt KW, Landzberg MJ, Economy KE, Khairy P. Pregnant women with congenital heart disease: cardiac, an anaesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010; 8(3): 439-448. doi: 10.1586/erc.09.179
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39(34): 3165-3241. doi: 10.1093/eurheartj/ehy340